VTRS
Viatris Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$16.88
−0.35%Forward multiples
Based on analyst estimates
- P/E forward
- 6.64x
- P/E 2026E
- 6.79x
- P/E 2027E
- 6.35x
- P/E 2028E
- 5.85x
- P/S forward
- 1.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.36x
- Price / sales
- 1.32x
- Price / cash flow
- 8.32x
Enterprise value
- Enterprise value
- $31.5B
- EV / sales
- 2.14x
- EV / EBITDA
- 11.93x
- EV / EBIT
- -360.87x
- Market cap
- $19.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026